R Stribling
Overview
Explore the profile of R Stribling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
SUSSMAN N, Kaza V, Barshes N, Stribling R, Goss J, OMahony C, et al.
Am J Transplant
. 2006 Jun;
6(9):2177-82.
PMID: 16796721
Severe portopulmonary hypertension (POPH) is an absolute contraindication to orthotopic liver transplantation (OLT). Vasodilators have been used, but the safety of subsequent transplantation and the reversibility of pulmonary hypertension after...
2.
Goss J, Stribling R, MARTIN P
Clin Liver Dis
. 2004 Nov;
2(1):187-210.
PMID: 15560053
Liver replacement provides an effective method of replacing a failing liver, and corrects the underlying defect in many metabolic conditions. Results of liver transplantation for metabolic diseases have been encouraging,...
3.
Schiodt F, Atillasoy E, Shakil A, Schiff E, Caldwell C, Kowdley K, et al.
Liver Transpl Surg
. 1999 Jan;
5(1):29-34.
PMID: 9873089
Little information is available on acute liver failure (ALF) in the United States. We gathered demographic data retrospectively for a 2-year period from July 1994 to June 1996 on all...
4.
Farmer D, McDiarmid S, Smith C, Stribling R, Seu P, Ament M, et al.
Transplant Proc
. 1998 Sep;
30(6):2533-4.
PMID: 9745474
No abstract available.
5.
Markowitz J, MARTIN P, Conrad A, Markmann J, Seu P, Yersiz H, et al.
Hepatology
. 1998 Aug;
28(2):585-9.
PMID: 9696028
Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with...
6.
Ghobrial R, Colquhoun S, Rosen H, HOLLIS P, Ponthieux S, Pakrasi A, et al.
Transplant Proc
. 1998 Jun;
30(4):1470-1.
PMID: 9636597
No abstract available.
7.
Markowitz J, Seu P, Goss J, Yersiz H, Markmann J, Farmer D, et al.
Transplantation
. 1998 Mar;
65(4):570-2.
PMID: 9500634
Background: Although jejunoileal bypass results in end-stage liver disease in up to 100% of patients, little is known about outcome after liver transplantation. Methods: The clinical courses of six patients...
8.
Markmann J, Markowitz J, Yersiz H, Morrisey M, Farmer D, FARMER D, et al.
Ann Surg
. 1997 Nov;
226(4):408-18; discussion 418-20.
PMID: 9351709
Objective: The authors determined the long-term outcome of patients undergoing hepatic retransplantation at their institution. Donor, operative, and recipient factors impacting on outcome as well as parameters of patient resource...
9.
Goss J, Schiller G, MARTIN P, Seu P, Stribling R, McDiarmid S, et al.
Hepatology
. 1997 Oct;
26(4):865-9.
PMID: 9328306
The clinical characteristics and outcome of posttransplantation aplastic anemia (AA) were determined in 12 of 1,736 patients (0.007%) undergoing orthotopic liver transplantation (OLT) that were afflicted with AA. None of...
10.
Stribling R, Brunette E, Liggitt D, Gaensler K, Debs R
Proc Natl Acad Sci U S A
. 1992 Dec;
89(23):11277-81.
PMID: 1454808
The ability to express transgenes selectively within the lung will greatly facilitate the development of gene therapy for a variety of human diseases. We have demonstrated that aerosol administration of...